Sheryl Bauer

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.

Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom.

Part of Aryt Industries Ltd., Technology Systems is an American company with five decades of ocean domain experience. The company's unique blend of editorial and marketing expertise helps their industry clients to expand their reach and deepen their message. Technology Systems was acquired by Aryt Industries Ltd. on September 12, 2000 for $5 million.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.

Women in Bio, Inc. is an organization that supports women in the life sciences industry. The non-profit company is based in Bethesda, MD and has subsidiaries in the United States. The organization has 13 chapters in the United States and is funded by sponsors and partners who are dedicated to supporting diversity and inclusion for women of all ages. Founded in 2002, it offers professional educational programs, peer-to-peer learning, mentoring, and networking opportunities for women at all career levels. Women in Bio was founded by Faith L. Charles and Cynthia Wong Hu.

Licensing Executives Society USA & Canada, Inc. is an association that operates for intellectual property, technology, and business development professionals. The non-profit company is based in Reston, VA. The company was founded in 1965.

Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA.

Part of Jubilant Pharmova Ltd., Jubilant Life Sciences (USA), Inc. is a company that wholesales pharmaceuticals. The company is based in Bedminster, NJ.

Vallinex, Inc. provides chronic pain relief products. Its product, VLNX-4975 is used to treat the osteoarthritis and other chronic pain conditions. The company is headquartered in Baltimore, MD.

KMG Japan, Inc. provides business support services. The private company is based in Minato Ku, Japan.

Traxion Therapeutics, Inc. develops drugs for intractable pain. The private company is based in Baltimore, MD. The company was founded by Kerrie L. Brady.

BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation.

R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.

AyuGen Biosciences Pvt Ltd. is a private organization founded in 2005 that focuses on specialized genomic tests and services. The private company is based in Pune, India. The Indian company's mission is to provide world-class preventive and diagnostic genomic tests to correctly identify the cause of the disease, and subsequently treat it with the correct medicine and right dose to minimize potential side effects. AyuGen aims to bridge the gaps between the current medical practices and the new "personalized" genomic based medical practices for prevention and better treatment.

ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA.

Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida.